MediciNova
MNOV
30 hedge funds and large institutions have $10.4M invested in MediciNova in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 6 closing their positions.
54% more call options, than puts
Call options by funds: $20K | Put options by funds: $13K
47% more capital invested
Capital invested by funds: $7.04M → $10.4M (+$3.32M)
0.29% more ownership
Funds ownership: 9.76% → 10.05% (+0.29%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 33 → 30 (-3)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$452K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$69.8K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$67.8K |
| 4 |
Jane Street
New York
|
+$20.9K |
| 5 |
Goldman Sachs
New York
|
+$15.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$337K |
| 2 |
Charles Schwab
San Francisco,
California
|
-$93.6K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$62.6K |
| 4 |
Renaissance Technologies
New York
|
-$34.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$24.9K |
MNOV Hedge Fund Activity: Q3 2024 in Review
30 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q3 2024, worth a combined $10.4M — up 47% from $7.04M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MNOV and 3 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 6 added.
The largest buyer was UBS Group, adding an estimated $452K. The largest seller was Bank of Montreal, exiting entirely with an estimated $337K sold.
- 30 institutional investors held MediciNova (MNOV) as of Q3 2024, down from 33 in Q2 2024.
- Funds reported $10.4M of MediciNova stock for Q3 2024, up 47% quarter-over-quarter.
- 3 funds opened new MediciNova positions in Q3 2024 and 6 closed out, a net change of -3 holders.
- The largest MediciNova buyer in Q3 2024 was UBS Group, an estimated $452K added.
- The largest MediciNova seller in Q3 2024 was Bank of Montreal, an estimated $337K sold.
Based on aggregated 13F filings for Q3 2024.